Federal contract award

75N91021F00014

NCI-DCP-21-0103 COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTION SHIP TRIAL

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NCI
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle75N91019D00024
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$8.0M
Current contract value$8.0M
Potential contract value / ceiling$8.0M
Start dateSep 14, 2021
Current end dateDec 31, 2026
Potential end dateDec 31, 2026
Latest award activityJun 12, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 12, 2026P00004$0NCI-DCP-21-0103 COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTION (SHIP) TRIAL
Jun 25, 2025P00003$0NCI-DCP-21-0103 COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTION (SHIP) TRIAL
Jul 10, 2023P00002$0NCI-DCP-21-0103 COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTION (SHIP) TRIAL
Sep 15, 2022P00001$1.9MNCI-DCP-21-0103 COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTION (SHIP) TRIAL
Sep 14, 20210$6.1MNCI-DCP-21-0103 COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTION SHIP TRIAL

Estimated positioning window

Nov 1, 2026 – Jan 30, 2027

Recompete signal:
75/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 75/100. Available recorded signals: 70 points.

Contract end 2026-12-31 (60 days from calculation)
+35 points
240 historical awards in this buyer and category group
+15 points
5 recorded award transactions
+10 points
Latest award action: 2026-06-12
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+0 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.